topic

795 Paclitaxel liposome plus immunotherapy for unresectable advanced non-small cell lung cancer: a real-world study
Yanjie Niu, Jian Ni, Di Zheng, Hao Ding, Yizhuo Zhao, Wei Heng, Yanhong Shang, Xiaoming Tan, Jiying Wang, Jingjing Yan, Meili Ma, Liyan Jiang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A893; DOI: 10.1136/jitc-2023-SITC2023.0795
796 Pegylated liposomal doxorubicin chemotherapy, Flt3 ligand, and CD40 agonist triplet combination improves tumor control in breast cancers
Shruthi Nooka, Preteesh Leo Mylabathula, James Zhu, Ashley Vu, Sharda Kumari, Isaac Chan, Sangeetha M Reddy

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A894; DOI: 10.1136/jitc-2023-SITC2023.0796
797 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2 negative metastatic breast cancer
Changhee Park, Koung Jin Suh, Se Hyun Kim, Seock-Ah Im, Min Hwan Kim, Jae Ho Jeong, Kyoung Eun Lee, Yeon Hee Park, Hee-Jun Kim, Eun Kyung Cho, In Sil Choi, Seung-Jae Noh, Inkyung Shin, Dae-Yeon Cho, Jeehyun Kim

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A895; DOI: 10.1136/jitc-2023-SITC2023.0797
798 TGFβ blockade in pancreatic cancer enhances sensitivity to combination chemotherapy
Li Qiang, Megan Hoffman, Lestat Ali, Jaime Ivan Castillo Silva, Ayantu Temesgen, Patrick Lenehan, Lauren Kageler, Jennifer Wang, Elisa Bello, Victoire Cardot-Ruffino, Giselle Uribe, Annan Yang, Michael Dougan, Andrew J Aguirre, Srivatsan Raghavan, Marc Pelletier, Viviana Cremasco, Stephanie Dougan

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A896; DOI: 10.1136/jitc-2023-SITC2023.0798
799 Combination intraperitoneal chemoimmunotherapy triggers a T-cell chemotactic locoregional response in patients with recurrent platinum-sensitive ovarian cancer
Mackenzy Radolec, Brian Orr, Lixin Zhang, Mary Strange, Syed Zaidi, Robert Edwards, Anda Vlad

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A897-A898; DOI: 10.1136/jitc-2023-SITC2023.0799
801 Risk-benefit ratio in immunotherapy (IO) with or without chemotherapy (CT) according to PD-L1 expression: a model-based approach to inform treatment decisions in metastatic non-small cell lung cancer
Molly Zhao, Naveen Mangal, Matthew L Zierhut, Han Witjes, Ting Chen, Thao Dang, Ana Ruiz, Sandhya Girish, Sreeneeranj Kasichayanula

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A899-A900; DOI: 10.1136/jitc-2023-SITC2023.0801
803 Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
Kristin G Anderson, Yapeng Su, Madison G Burnett, Breanna M Bates, Magdalia L Suarez Gutierrez, Susan L Ruskin, Valentin Voillet, Raphael Gottardo, Philip D Greenberg

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A901; DOI: 10.1136/jitc-2023-SITC2023.0803
804 Anti-tumor effect of a novel Vβ TCR-targeting bifunctional agent in combination with anti-PD1 in checkpoint refractory murine lung cancer models
Shantel Angstadt, Lucas A Horn, Kristen Fousek, Haiyan Qin, Madan Katragadda, Jacques Moisan, Andrew Bayliffe, Jeffrey Schlom, Claudia Palena

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A902; DOI: 10.1136/jitc-2023-SITC2023.0804
805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC)
Victor Arias, Tatiana Kudling, James Clubb, Lyna Haybout, Elise Jirovec, Santeri A Pakola, Saru Basnet, Dafne CA Quixabeira, Otto Hemminki, Susanna AM Grönberg-Vähä-Koskela, Joao Manuel Santos, Victor Cervera-Carrascon, Akseli Hemminki

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A903; DOI: 10.1136/jitc-2023-SITC2023.0805
806 Oncolytic adenovirus coding for human Mucin1 T cell engager with interleukin-2 potentiates anti-tumor T cell responses against tumors
Saru Basnet, Mirte Van der Heijden, Elise Jirovec, James Clubb, Susanna AM Grönberg-Vähä-Koskela, Victor Arias, Santeri A Pakola, Anna Kanerva, Dafne Alves Quixabeira, Joao Manuel Santos, Lyna Haybout, Tatiana Kudling, Akseli Hemminki

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A904; DOI: 10.1136/jitc-2023-SITC2023.0806

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages